+1 347 708 0418
The Clinical Oncology Next Generation Sequencing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Clinical Oncology Next Generation Sequencing size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Clinical Oncology Next Generation Sequencing market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Clinical Oncology Next Generation Sequencing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Whole Genome Sequencing
Whole Exome Sequencing
Targeted Sequencing & Resequencing Centrifuges
Market segment by Application, can be divided into
Hospitals
Clinics
Laboratories
Market segment by players, this report covers
Illumina, Inc.
Thermo Fisher Scientific
F. Hoffmann-La Roche Ltd.
Agilent Technologies
Myriad Genetics
Beijing Genomics Institute (BGI)
Perkin Elmer
Foundation Medicine
Pacific Bioscience
Oxford Nanopore Technologies Ltd.
Paradigm Diagnostics
Caris Life Sciences
Partek, Inc.
Eurofins Scientific S.E.
Qiagen N.V.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Clinical Oncology Next Generation Sequencing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Clinical Oncology Next Generation Sequencing, with revenue, gross margin and global market share of Clinical Oncology Next Generation Sequencing from 2019 to 2021.
Chapter 3, the Clinical Oncology Next Generation Sequencing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Clinical Oncology Next Generation Sequencing market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Clinical Oncology Next Generation Sequencing research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Clinical Oncology Next Generation Sequencing
1.2 Classification of Clinical Oncology Next Generation Sequencing by Type
1.2.1 Overview: Global Clinical Oncology Next Generation Sequencing Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Clinical Oncology Next Generation Sequencing Revenue Market Share by Type in 2020
1.2.3 Whole Genome Sequencing
1.2.4 Whole Exome Sequencing
1.2.5 Targeted Sequencing & Resequencing Centrifuges
1.3 Global Clinical Oncology Next Generation Sequencing Market by Application
1.3.1 Overview: Global Clinical Oncology Next Generation Sequencing Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Laboratories
1.4 Global Clinical Oncology Next Generation Sequencing Market Size & Forecast
1.5 Global Clinical Oncology Next Generation Sequencing Market Size and Forecast by Region
1.5.1 Global Clinical Oncology Next Generation Sequencing Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Clinical Oncology Next Generation Sequencing Market Size by Region, (2016-2021)
1.5.3 North America Clinical Oncology Next Generation Sequencing Market Size and Prospect (2016-2026)
1.5.4 Europe Clinical Oncology Next Generation Sequencing Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Clinical Oncology Next Generation Sequencing Market Size and Prospect (2016-2026)
1.5.6 South America Clinical Oncology Next Generation Sequencing Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Clinical Oncology Next Generation Sequencing Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Clinical Oncology Next Generation Sequencing Market Drivers
1.6.2 Clinical Oncology Next Generation Sequencing Market Restraints
1.6.3 Clinical Oncology Next Generation Sequencing Trends Analysis
2 Company Profiles
2.1 Illumina, Inc.
2.1.1 Illumina, Inc. Details
2.1.2 Illumina, Inc. Major Business
2.1.3 Illumina, Inc. Clinical Oncology Next Generation Sequencing Product and Solutions
2.1.4 Illumina, Inc. Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Illumina, Inc. Recent Developments and Future Plans
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific Clinical Oncology Next Generation Sequencing Product and Solutions
2.2.4 Thermo Fisher Scientific Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.3 F. Hoffmann-La Roche Ltd.
2.3.1 F. Hoffmann-La Roche Ltd. Details
2.3.2 F. Hoffmann-La Roche Ltd. Major Business
2.3.3 F. Hoffmann-La Roche Ltd. Clinical Oncology Next Generation Sequencing Product and Solutions
2.3.4 F. Hoffmann-La Roche Ltd. Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
2.4 Agilent Technologies
2.4.1 Agilent Technologies Details
2.4.2 Agilent Technologies Major Business
2.4.3 Agilent Technologies Clinical Oncology Next Generation Sequencing Product and Solutions
2.4.4 Agilent Technologies Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Agilent Technologies Recent Developments and Future Plans
2.5 Myriad Genetics
2.5.1 Myriad Genetics Details
2.5.2 Myriad Genetics Major Business
2.5.3 Myriad Genetics Clinical Oncology Next Generation Sequencing Product and Solutions
2.5.4 Myriad Genetics Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Myriad Genetics Recent Developments and Future Plans
2.6 Beijing Genomics Institute (BGI)
2.6.1 Beijing Genomics Institute (BGI) Details
2.6.2 Beijing Genomics Institute (BGI) Major Business
2.6.3 Beijing Genomics Institute (BGI) Clinical Oncology Next Generation Sequencing Product and Solutions
2.6.4 Beijing Genomics Institute (BGI) Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Beijing Genomics Institute (BGI) Recent Developments and Future Plans
2.7 Perkin Elmer
2.7.1 Perkin Elmer Details
2.7.2 Perkin Elmer Major Business
2.7.3 Perkin Elmer Clinical Oncology Next Generation Sequencing Product and Solutions
2.7.4 Perkin Elmer Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Perkin Elmer Recent Developments and Future Plans
2.8 Foundation Medicine
2.8.1 Foundation Medicine Details
2.8.2 Foundation Medicine Major Business
2.8.3 Foundation Medicine Clinical Oncology Next Generation Sequencing Product and Solutions
2.8.4 Foundation Medicine Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Foundation Medicine Recent Developments and Future Plans
2.9 Pacific Bioscience
2.9.1 Pacific Bioscience Details
2.9.2 Pacific Bioscience Major Business
2.9.3 Pacific Bioscience Clinical Oncology Next Generation Sequencing Product and Solutions
2.9.4 Pacific Bioscience Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Pacific Bioscience Recent Developments and Future Plans
2.10 Oxford Nanopore Technologies Ltd.
2.10.1 Oxford Nanopore Technologies Ltd. Details
2.10.2 Oxford Nanopore Technologies Ltd. Major Business
2.10.3 Oxford Nanopore Technologies Ltd. Clinical Oncology Next Generation Sequencing Product and Solutions
2.10.4 Oxford Nanopore Technologies Ltd. Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Oxford Nanopore Technologies Ltd. Recent Developments and Future Plans
2.11 Paradigm Diagnostics
2.11.1 Paradigm Diagnostics Details
2.11.2 Paradigm Diagnostics Major Business
2.11.3 Paradigm Diagnostics Clinical Oncology Next Generation Sequencing Product and Solutions
2.11.4 Paradigm Diagnostics Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Paradigm Diagnostics Recent Developments and Future Plans
2.12 Caris Life Sciences
2.12.1 Caris Life Sciences Details
2.12.2 Caris Life Sciences Major Business
2.12.3 Caris Life Sciences Clinical Oncology Next Generation Sequencing Product and Solutions
2.12.4 Caris Life Sciences Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Caris Life Sciences Recent Developments and Future Plans
2.13 Partek, Inc.
2.13.1 Partek, Inc. Details
2.13.2 Partek, Inc. Major Business
2.13.3 Partek, Inc. Clinical Oncology Next Generation Sequencing Product and Solutions
2.13.4 Partek, Inc. Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Partek, Inc. Recent Developments and Future Plans
2.14 Eurofins Scientific S.E.
2.14.1 Eurofins Scientific S.E. Details
2.14.2 Eurofins Scientific S.E. Major Business
2.14.3 Eurofins Scientific S.E. Clinical Oncology Next Generation Sequencing Product and Solutions
2.14.4 Eurofins Scientific S.E. Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Eurofins Scientific S.E. Recent Developments and Future Plans
2.15 Qiagen N.V.
2.15.1 Qiagen N.V. Details
2.15.2 Qiagen N.V. Major Business
2.15.3 Qiagen N.V. Clinical Oncology Next Generation Sequencing Product and Solutions
2.15.4 Qiagen N.V. Clinical Oncology Next Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Qiagen N.V. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Clinical Oncology Next Generation Sequencing Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Clinical Oncology Next Generation Sequencing Players Market Share
3.2.2 Top 10 Clinical Oncology Next Generation Sequencing Players Market Share
3.2.3 Market Competition Trend
3.3 Clinical Oncology Next Generation Sequencing Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Clinical Oncology Next Generation Sequencing Revenue and Market Share by Type (2016-2021)
4.2 Global Clinical Oncology Next Generation Sequencing Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Clinical Oncology Next Generation Sequencing Revenue Market Share by Application (2016-2021)
5.2 Clinical Oncology Next Generation Sequencing Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Clinical Oncology Next Generation Sequencing Revenue by Type (2016-2026)
6.2 North America Clinical Oncology Next Generation Sequencing Revenue by Application (2016-2026)
6.3 North America Clinical Oncology Next Generation Sequencing Market Size by Country
6.3.1 North America Clinical Oncology Next Generation Sequencing Revenue by Country (2016-2026)
6.3.2 United States Clinical Oncology Next Generation Sequencing Market Size and Forecast (2016-2026)
6.3.3 Canada Clinical Oncology Next Generation Sequencing Market Size and Forecast (2016-2026)
6.3.4 Mexico Clinical Oncology Next Generation Sequencing Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Clinical Oncology Next Generation Sequencing Revenue by Type (2016-2026)
7.2 Europe Clinical Oncology Next Generation Sequencing Revenue by Application (2016-2026)
7.3 Europe Clinical Oncology Next Generation Sequencing Market Size by Country
7.3.1 Europe Clinical Oncology Next Generation Sequencing Revenue by Country (2016-2026)
7.3.2 Germany Clinical Oncology Next Generation Sequencing Market Size and Forecast (2016-2026)
7.3.3 France Clinical Oncology Next Generation Sequencing Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Clinical Oncology Next Generation Sequencing Market Size and Forecast (2016-2026)
7.3.5 Russia Clinical Oncology Next Generation Sequencing Market Size and Forecast (2016-2026)
7.3.6 Italy Clinical Oncology Next Generation Sequencing Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Clinical Oncology Next Generation Sequencing Revenue by Type (2016-2026)
8.2 Asia-Pacific Clinical Oncology Next Generation Sequencing Revenue by Application (2016-2026)
8.3 Asia-Pacific Clinical Oncology Next Generation Sequencing Market Size by Region
8.3.1 Asia-Pacific Clinical Oncology Next Generation Sequencing Revenue by Region (2016-2026)
8.3.2 China Clinical Oncology Next Generation Sequencing Market Size and Forecast (2016-2026)
8.3.3 Japan Clinical Oncology Next Generation Sequencing Market Size and Forecast (2016-2026)
8.3.4 South Korea Clinical Oncology Next Generation Sequencing Market Size and Forecast (2016-2026)
8.3.5 India Clinical Oncology Next Generation Sequencing Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Clinical Oncology Next Generation Sequencing Market Size and Forecast (2016-2026)
8.3.7 Australia Clinical Oncology Next Generation Sequencing Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Clinical Oncology Next Generation Sequencing Revenue by Type (2016-2026)
9.2 South America Clinical Oncology Next Generation Sequencing Revenue by Application (2016-2026)
9.3 South America Clinical Oncology Next Generation Sequencing Market Size by Country
9.3.1 South America Clinical Oncology Next Generation Sequencing Revenue by Country (2016-2026)
9.3.2 Brazil Clinical Oncology Next Generation Sequencing Market Size and Forecast (2016-2026)
9.3.3 Argentina Clinical Oncology Next Generation Sequencing Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Clinical Oncology Next Generation Sequencing Revenue by Type (2016-2026)
10.2 Middle East & Africa Clinical Oncology Next Generation Sequencing Revenue by Application (2016-2026)
10.3 Middle East & Africa Clinical Oncology Next Generation Sequencing Market Size by Country
10.3.1 Middle East & Africa Clinical Oncology Next Generation Sequencing Revenue by Country (2016-2026)
10.3.2 Turkey Clinical Oncology Next Generation Sequencing Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Clinical Oncology Next Generation Sequencing Market Size and Forecast (2016-2026)
10.3.4 UAE Clinical Oncology Next Generation Sequencing Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Clinical Oncology Next Generation Sequencing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Clinical Oncology Next Generation Sequencing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Clinical Oncology Next Generation Sequencing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Clinical Oncology Next Generation Sequencing Revenue (USD Million) by Region (2016-2021)
Table 5. Global Clinical Oncology Next Generation Sequencing Revenue Market Share by Region (2021-2026)
Table 6. Illumina, Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Illumina, Inc. Major Business
Table 8. Illumina, Inc. Clinical Oncology Next Generation Sequencing Product and Solutions
Table 9. Illumina, Inc. Clinical Oncology Next Generation Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Scientific Major Business
Table 12. Thermo Fisher Scientific Clinical Oncology Next Generation Sequencing Product and Solutions
Table 13. Thermo Fisher Scientific Clinical Oncology Next Generation Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. F. Hoffmann-La Roche Ltd. Corporate Information, Head Office, and Major Competitors
Table 15. F. Hoffmann-La Roche Ltd. Major Business
Table 16. F. Hoffmann-La Roche Ltd. Clinical Oncology Next Generation Sequencing Product and Solutions
Table 17. F. Hoffmann-La Roche Ltd. Clinical Oncology Next Generation Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Agilent Technologies Corporate Information, Head Office, and Major Competitors
Table 19. Agilent Technologies Major Business
Table 20. Agilent Technologies Clinical Oncology Next Generation Sequencing Product and Solutions
Table 21. Agilent Technologies Clinical Oncology Next Generation Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Myriad Genetics Corporate Information, Head Office, and Major Competitors
Table 23. Myriad Genetics Major Business
Table 24. Myriad Genetics Clinical Oncology Next Generation Sequencing Product and Solutions
Table 25. Myriad Genetics Clinical Oncology Next Generation Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Beijing Genomics Institute (BGI) Corporate Information, Head Office, and Major Competitors
Table 27. Beijing Genomics Institute (BGI) Major Business
Table 28. Beijing Genomics Institute (BGI) Clinical Oncology Next Generation Sequencing Product and Solutions
Table 29. Beijing Genomics Institute (BGI) Clinical Oncology Next Generation Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Perkin Elmer Corporate Information, Head Office, and Major Competitors
Table 31. Perkin Elmer Major Business
Table 32. Perkin Elmer Clinical Oncology Next Generation Sequencing Product and Solutions
Table 33. Perkin Elmer Clinical Oncology Next Generation Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Foundation Medicine Corporate Information, Head Office, and Major Competitors
Table 35. Foundation Medicine Major Business
Table 36. Foundation Medicine Clinical Oncology Next Generation Sequencing Product and Solutions
Table 37. Foundation Medicine Clinical Oncology Next Generation Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Pacific Bioscience Corporate Information, Head Office, and Major Competitors
Table 39. Pacific Bioscience Major Business
Table 40. Pacific Bioscience Clinical Oncology Next Generation Sequencing Product and Solutions
Table 41. Pacific Bioscience Clinical Oncology Next Generation Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Oxford Nanopore Technologies Ltd. Corporate Information, Head Office, and Major Competitors
Table 43. Oxford Nanopore Technologies Ltd. Major Business
Table 44. Oxford Nanopore Technologies Ltd. Clinical Oncology Next Generation Sequencing Product and Solutions
Table 45. Oxford Nanopore Technologies Ltd. Clinical Oncology Next Generation Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Paradigm Diagnostics Corporate Information, Head Office, and Major Competitors
Table 47. Paradigm Diagnostics Major Business
Table 48. Paradigm Diagnostics Clinical Oncology Next Generation Sequencing Product and Solutions
Table 49. Paradigm Diagnostics Clinical Oncology Next Generation Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Caris Life Sciences Corporate Information, Head Office, and Major Competitors
Table 51. Caris Life Sciences Major Business
Table 52. Caris Life Sciences Clinical Oncology Next Generation Sequencing Product and Solutions
Table 53. Caris Life Sciences Clinical Oncology Next Generation Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Partek, Inc. Corporate Information, Head Office, and Major Competitors
Table 55. Partek, Inc. Major Business
Table 56. Partek, Inc. Clinical Oncology Next Generation Sequencing Product and Solutions
Table 57. Partek, Inc. Clinical Oncology Next Generation Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Eurofins Scientific S.E. Corporate Information, Head Office, and Major Competitors
Table 59. Eurofins Scientific S.E. Major Business
Table 60. Eurofins Scientific S.E. Clinical Oncology Next Generation Sequencing Product and Solutions
Table 61. Eurofins Scientific S.E. Clinical Oncology Next Generation Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Qiagen N.V. Corporate Information, Head Office, and Major Competitors
Table 63. Qiagen N.V. Major Business
Table 64. Qiagen N.V. Clinical Oncology Next Generation Sequencing Product and Solutions
Table 65. Qiagen N.V. Clinical Oncology Next Generation Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Global Clinical Oncology Next Generation Sequencing Revenue (USD Million) by Players (2019-2021)
Table 67. Global Clinical Oncology Next Generation Sequencing Revenue Share by Players (2019-2021)
Table 68. Breakdown of Clinical Oncology Next Generation Sequencing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. Clinical Oncology Next Generation Sequencing Players Head Office, Products and Services Provided
Table 70. Clinical Oncology Next Generation Sequencing Mergers & Acquisitions in the Past Five Years
Table 71. Clinical Oncology Next Generation Sequencing New Entrants and Expansion Plans
Table 72. Global Clinical Oncology Next Generation Sequencing Revenue (USD Million) by Type (2016-2021)
Table 73. Global Clinical Oncology Next Generation Sequencing Revenue Share by Type (2016-2021)
Table 74. Global Clinical Oncology Next Generation Sequencing Revenue Forecast by Type (2021-2026)
Table 75. Global Clinical Oncology Next Generation Sequencing Revenue by Application (2016-2021)
Table 76. Global Clinical Oncology Next Generation Sequencing Revenue Forecast by Application (2021-2026)
Table 77. North America Clinical Oncology Next Generation Sequencing Revenue by Type (2016-2021) & (USD Million)
Table 78. North America Clinical Oncology Next Generation Sequencing Revenue by Type (2021-2026) & (USD Million)
Table 79. North America Clinical Oncology Next Generation Sequencing Revenue by Application (2016-2021) & (USD Million)
Table 80. North America Clinical Oncology Next Generation Sequencing Revenue by Application (2021-2026) & (USD Million)
Table 81. North America Clinical Oncology Next Generation Sequencing Revenue by Country (2016-2021) & (USD Million)
Table 82. North America Clinical Oncology Next Generation Sequencing Revenue by Country (2021-2026) & (USD Million)
Table 83. Europe Clinical Oncology Next Generation Sequencing Revenue by Type (2016-2021) & (USD Million)
Table 84. Europe Clinical Oncology Next Generation Sequencing Revenue by Type (2021-2026) & (USD Million)
Table 85. Europe Clinical Oncology Next Generation Sequencing Revenue by Application (2016-2021) & (USD Million)
Table 86. Europe Clinical Oncology Next Generation Sequencing Revenue by Application (2021-2026) & (USD Million)
Table 87. Europe Clinical Oncology Next Generation Sequencing Revenue by Country (2016-2021) & (USD Million)
Table 88. Europe Clinical Oncology Next Generation Sequencing Revenue by Country (2021-2026) & (USD Million)
Table 89. Asia-Pacific Clinical Oncology Next Generation Sequencing Revenue by Type (2016-2021) & (USD Million)
Table 90. Asia-Pacific Clinical Oncology Next Generation Sequencing Revenue by Type (2021-2026) & (USD Million)
Table 91. Asia-Pacific Clinical Oncology Next Generation Sequencing Revenue by Application (2016-2021) & (USD Million)
Table 92. Asia-Pacific Clinical Oncology Next Generation Sequencing Revenue by Application (2021-2026) & (USD Million)
Table 93. Asia-Pacific Clinical Oncology Next Generation Sequencing Revenue by Region (2016-2021) & (USD Million)
Table 94. Asia-Pacific Clinical Oncology Next Generation Sequencing Revenue by Region (2021-2026) & (USD Million)
Table 95. South America Clinical Oncology Next Generation Sequencing Revenue by Type (2016-2021) & (USD Million)
Table 96. South America Clinical Oncology Next Generation Sequencing Revenue by Type (2021-2026) & (USD Million)
Table 97. South America Clinical Oncology Next Generation Sequencing Revenue by Application (2016-2021) & (USD Million)
Table 98. South America Clinical Oncology Next Generation Sequencing Revenue by Application (2021-2026) & (USD Million)
Table 99. South America Clinical Oncology Next Generation Sequencing Revenue by Country (2016-2021) & (USD Million)
Table 100. South America Clinical Oncology Next Generation Sequencing Revenue by Country (2021-2026) & (USD Million)
Table 101. Middle East & Africa Clinical Oncology Next Generation Sequencing Revenue by Type (2016-2021) & (USD Million)
Table 102. Middle East & Africa Clinical Oncology Next Generation Sequencing Revenue by Type (2021-2026) & (USD Million)
Table 103. Middle East & Africa Clinical Oncology Next Generation Sequencing Revenue by Application (2016-2021) & (USD Million)
Table 104. Middle East & Africa Clinical Oncology Next Generation Sequencing Revenue by Application (2021-2026) & (USD Million)
Table 105. Middle East & Africa Clinical Oncology Next Generation Sequencing Revenue by Country (2016-2021) & (USD Million)
Table 106. Middle East & Africa Clinical Oncology Next Generation Sequencing Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Clinical Oncology Next Generation Sequencing Picture
Figure 2. Global Clinical Oncology Next Generation Sequencing Revenue Market Share by Type in 2020
Figure 3. Whole Genome Sequencing
Figure 4. Whole Exome Sequencing
Figure 5. Targeted Sequencing & Resequencing Centrifuges
Figure 6. Clinical Oncology Next Generation Sequencing Revenue Market Share by Application in 2020
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Laboratories Picture
Figure 10. Global Clinical Oncology Next Generation Sequencing Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Clinical Oncology Next Generation Sequencing Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Clinical Oncology Next Generation Sequencing Revenue Market Share by Region (2016-2026)
Figure 13. Global Clinical Oncology Next Generation Sequencing Revenue Market Share by Region in 2020
Figure 14. North America Clinical Oncology Next Generation Sequencing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Clinical Oncology Next Generation Sequencing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Clinical Oncology Next Generation Sequencing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Clinical Oncology Next Generation Sequencing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Clinical Oncology Next Generation Sequencing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Clinical Oncology Next Generation Sequencing Market Drivers
Figure 20. Clinical Oncology Next Generation Sequencing Market Restraints
Figure 21. Clinical Oncology Next Generation Sequencing Market Trends
Figure 22. Illumina, Inc. Recent Developments and Future Plans
Figure 23. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 24. F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
Figure 25. Agilent Technologies Recent Developments and Future Plans
Figure 26. Myriad Genetics Recent Developments and Future Plans
Figure 27. Beijing Genomics Institute (BGI) Recent Developments and Future Plans
Figure 28. Perkin Elmer Recent Developments and Future Plans
Figure 29. Foundation Medicine Recent Developments and Future Plans
Figure 30. Pacific Bioscience Recent Developments and Future Plans
Figure 31. Oxford Nanopore Technologies Ltd. Recent Developments and Future Plans
Figure 32. Paradigm Diagnostics Recent Developments and Future Plans
Figure 33. Caris Life Sciences Recent Developments and Future Plans
Figure 34. Partek, Inc. Recent Developments and Future Plans
Figure 35. Eurofins Scientific S.E. Recent Developments and Future Plans
Figure 36. Qiagen N.V. Recent Developments and Future Plans
Figure 37. Global Clinical Oncology Next Generation Sequencing Revenue Share by Players in 2020
Figure 38. Clinical Oncology Next Generation Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 39. Global Top 3 Players Clinical Oncology Next Generation Sequencing Revenue Market Share in 2020
Figure 40. Global Top 10 Players Clinical Oncology Next Generation Sequencing Revenue Market Share in 2020
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 42. Global Clinical Oncology Next Generation Sequencing Revenue Share by Type in 2020
Figure 43. Global Clinical Oncology Next Generation Sequencing Market Share Forecast by Type (2021-2026)
Figure 44. Global Clinical Oncology Next Generation Sequencing Revenue Share by Application in 2020
Figure 45. Global Clinical Oncology Next Generation Sequencing Market Share Forecast by Application (2021-2026)
Figure 46. North America Clinical Oncology Next Generation Sequencing Sales Market Share by Type (2016-2026)
Figure 47. North America Clinical Oncology Next Generation Sequencing Sales Market Share by Application (2016-2026)
Figure 48. North America Clinical Oncology Next Generation Sequencing Revenue Market Share by Country (2016-2026)
Figure 49. United States Clinical Oncology Next Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Canada Clinical Oncology Next Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Mexico Clinical Oncology Next Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Europe Clinical Oncology Next Generation Sequencing Sales Market Share by Type (2016-2026)
Figure 53. Europe Clinical Oncology Next Generation Sequencing Sales Market Share by Application (2016-2026)
Figure 54. Europe Clinical Oncology Next Generation Sequencing Revenue Market Share by Country (2016-2026)
Figure 55. Germany Clinical Oncology Next Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. France Clinical Oncology Next Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. United Kingdom Clinical Oncology Next Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Russia Clinical Oncology Next Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Italy Clinical Oncology Next Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Asia-Pacific Clinical Oncology Next Generation Sequencing Sales Market Share by Type (2016-2026)
Figure 61. Asia-Pacific Clinical Oncology Next Generation Sequencing Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Clinical Oncology Next Generation Sequencing Revenue Market Share by Region (2016-2026)
Figure 63. China Clinical Oncology Next Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Japan Clinical Oncology Next Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South Korea Clinical Oncology Next Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. India Clinical Oncology Next Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Southeast Asia Clinical Oncology Next Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Australia Clinical Oncology Next Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South America Clinical Oncology Next Generation Sequencing Sales Market Share by Type (2016-2026)
Figure 70. South America Clinical Oncology Next Generation Sequencing Sales Market Share by Application (2016-2026)
Figure 71. South America Clinical Oncology Next Generation Sequencing Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Clinical Oncology Next Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Clinical Oncology Next Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East and Africa Clinical Oncology Next Generation Sequencing Sales Market Share by Type (2016-2026)
Figure 75. Middle East and Africa Clinical Oncology Next Generation Sequencing Sales Market Share by Application (2016-2026)
Figure 76. Middle East and Africa Clinical Oncology Next Generation Sequencing Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Clinical Oncology Next Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Clinical Oncology Next Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. UAE Clinical Oncology Next Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source
Buy
